Report Description

Global Eye Drop Market stood at USD13530 million in 2021 and is expected to grow at a steady CAGR of 6.46% during the forecast period. This is due to the increasing frequency of many infectious diseases around the world. Furthermore, the sudden onset and spread of the COVID-19 pandemic has resulted in an upsurge in demand for eye drops used to treat COVID-19-related ocular allergies. This, in turn, supported market expansion in 2020.

Rising public awareness of the importance of eye care, widespread adoption of digital devices, an increase in the number of cataract and other eye-related surgeries that necessitate the use of eye drops after surgery, and an increase in the geriatric population, who are more susceptible to eye diseases, will all contribute to market growth in the coming years. Also, flourishing healthcare industry and increasing healthcare expenditure by both the governments and population across the globe is expected to foster the market growth during the forecast period.

Sudden Outbreak & Spread of COVID-19 Driving Market Growth

The growing number of people infected by the virus significantly changed the scenario of medical care across the world. Certain eye drops considered beneficial in the prevention of SARS-CoV-2 infection via the surface of the eye. For instance, Trehalose is a common ocular pharmaceutical drug that is used as an eye drop.

Trehalose is a basic plant-based sugar that has been shown to influence autophagy. It has antiviral effects, such as inducing type 1 interferons and aiding intracellular virus lysosomal breakdown. It also blocks clathrin-mediated viral endocytosis and prevents fusion of viral and host cell endosomal membranes by preventing endosomal acidification.

Growing Prevalence of Dry Eye Disease Supporting Market Growth

The growing case of Dry eye disease enhance the growth rate of Eye Drop Market globally. For instance, in 2021, according to National Center for Biotechnology Information, global dry eye disease was estimated at 11.59%. For symptomatic disease, the estimate was 9.12% with women 9.5% and men 6.8% (SD = 0.06).

The prevalence was lowest in North America, with 4.6% and highest in Africa with 47.9%. For signs, the prevalence was 35.2% with woman 34.7% and men 37.6%. North America showed the lowest regional prevalence, with 3.5% and Eastern Asia the highest with 42.8%.

Launching of New Eye Drops Aids Market Growth

Various Eye care companies are launching new and effective eye drops in the market for the treatment of various eye related diseases and disorders to meet the demand of the consumers. For Instance, in 2021, Nova Bay Pharmaceuticals announced the launch of Avenova Lubricating Eye Drops for the treatment of dry eye symptoms.

Also, in October 2021, Allergan, an AbbVie company, announced the FDA approval of the eye drop, Vuity, for the treatment of presbyopia which could replace reading glasses for millions.

Increasing Healthcare Expenditure to Support Market Growth

The existing healthcare industry is predicted to benefit from rising healthcare expenditures in various countries throughout the world. This, in turn, is predicted to have a positive impact on market growth through 2027. According to the WHO, worldwide healthcare spending was over USD8.3 trillion in 2018, accounting for about 10% of global GDP, and is anticipated to reach USD10 trillion by 2024.

The sudden out break and spread of the COVID-19 pandemic, on the other hand, raised demand for healthcare services, while spending on lifestyle and other diseases decreased across countries. Because of rising demand for other healthcare services, this expenditure is likely to rise in the coming years, creating potential for the Global Eye Drop Market.


Click here to download the sample

Market Segmentation

The Global Eye Drop Market is segmented based on type, drug class, disease indication, distribution channel, company, and regional distribution.

Based on type, the market can be split into Prescription and Over-the-Counter.

Based on Drug Class, the market can be divided into Anti-allergy, Anti-glaucoma, Anti-inflammatory, Anti-VEGF, and Others.

Based on disease indication, the market is divided into Eye Allergy, Glaucoma, Eye Infections, Dry Eye Diseases, and Retinal Disorders.

Based on the Distribution Channel, the market segmented into Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy.

Company Profiles

Johnson & Johnson Inc, Genentech, Inc. (Roche), Alcon Inc., Pfizer, Inc., Bausch Health Companies, Inc., Bayer Corporation, Allergan, Inc. (AbbVie), Abbott Laboratories, Inc., KC Pharmaceuticals, Inc., Akorn, Inc. are among the major market players in the global platform that lead the market growth of the global Eye Drop Market.

Attribute

Details

Market size value in 2021

USD 13530.00 Million

Revenue Forecast in 2027

USD 19758.00 Million

United States Market size value in 2021

USD 4001.46 Million

Growth Rate

6.46%

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Type

·         Drug Class

·         Disease Indication

·         Distribution Channel

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; Russia Federation; United Kingdom; Germany; France; Spain; Italy; China; India; Japan; Australia; South Korea; Indonesia; Brazil; Argentina; Colombia; Turkey; South Africa; Saudi Arabia; UAE; Kuwait

Key Companies Profiled

Johnson & Johnson Inc, Genentech, Inc. (Roche), Alcon Inc., Pfizer, Inc., Bausch Health Companies, Inc., Bayer Corporation, Allergan, Inc. (AbbVie), Abbott Laboratories, Inc., KC Pharmaceuticals, Inc., Akorn, Inc

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 

Report Scope:

In this report, Global Eye Drop Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Eye Drop Market, By Type:
    • Prescription
    • Over-The-Counter
  • Eye Drop Market, By Drug Class:
    • Anti-allergy
    • Anti-glaucoma
    • Anti-inflammatory
    • Anti-VEGF
    • Others
  • Eye Drop Market, By Disease Indication:
    • Eye Allergy
    • Glaucoma
    • Eye Infections
    • Dry Eye Diseases
    • Retinal Disorders
  • Eye Drop Market, By Distribution Channel:
    • Hospitals Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Eye Drop Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Russia Federation
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Indonesia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • Turkey
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Eye Drop Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Eye Drop Market

5.    Voice of Customer

5.1.  Brand Awareness

5.2.  Factors Contributing to demand for Eye Drops

5.3.  Demand, By Drug Class

5.4.  Demand, By Disease Indication

5.5.  Preference, By Distribution Channel

6.    Global Eye Drop Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Prescription v/s Over-The-Counter)

6.2.2.     By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others)

6.2.3.     By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others)

6.2.4.     By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    North America Eye Drop Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Drug Class

7.2.3.     By Disease Indication

7.2.4.     By Distribution Channel

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Eye Drop Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Drug Class

7.3.1.2.3.             By Disease Indication

7.3.1.2.4.             By Distribution Channel

7.3.2.     Canada Eye Drop Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Drug Class

7.3.2.2.3.             By Disease Indication

7.3.2.2.4.             By Distribution Channel

7.3.3.     Mexico Eye Drop Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Drug Class

7.3.3.2.3.             By Disease Indication

7.3.3.2.4.             By Distribution Channel

8.    Europe Eye Drop Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Drug Class

8.2.3.     By Disease Indication

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Russia Federation Eye Drop Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Drug Class

8.3.1.2.3.             By Disease Indication

8.3.1.2.4.             By Distribution Channel

8.3.2.     United Kingdom Eye Drop Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Drug Class

8.3.2.2.3.             By Disease Indication

8.3.2.2.4.             By Distribution Channel

8.3.3.     Germany Eye Drop Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Drug Class

8.3.3.2.3.             By Disease Indication

8.3.3.2.4.             By Distribution Channel

8.3.4.     France Eye Drop Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Drug Class

8.3.4.2.3.             By Disease Indication

8.3.4.2.4.             By Distribution Channel

8.3.5.     Spain Eye Drop Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Drug Class

8.3.5.2.3.             By Disease Indication

8.3.5.2.4.             By Distribution Channel

8.3.6.     Italy Eye Drop Market Outlook

8.3.6.1.         Market Size & Forecast

8.3.6.1.1.             By Value

8.3.6.2.         Market Share & Forecast

8.3.6.2.1.             By Type

8.3.6.2.2.             By Drug Class

8.3.6.2.3.             By Disease Indication

8.3.6.2.4.             By Distribution Channel

9.    Asia-Pacific Eye Drop Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Drug Class

9.2.3.     By Disease Indication

9.2.4.     By Distribution Channel

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Eye Drop Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Drug Class

9.3.1.2.3.             By Disease Indication

9.3.1.2.4.             By Distribution Channel

9.3.2.     India Eye Drop Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Drug Class

9.3.2.2.3.             By Disease Indication

9.3.2.2.4.             By Distribution Channel

9.3.3.     Japan Eye Drop Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Drug Class

9.3.3.2.3.             By Disease Indication

9.3.3.2.4.             By Distribution Channel

9.3.4.     Australia Eye Drop Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type

9.3.4.2.2.             By Drug Class

9.3.4.2.3.             By Disease Indication

9.3.4.2.4.             By Distribution Channel

9.3.5.     South Korea Eye Drop Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By Drug Class

9.3.5.2.3.             By Disease Indication

9.3.5.2.4.             By Distribution Channel

9.3.6.     Indonesia Eye Drop Market Outlook

9.3.6.1.         Market Size & Forecast

9.3.6.1.1.             By Value

9.3.6.2.         Market Share & Forecast

9.3.6.2.1.             By Type

9.3.6.2.2.             By Drug Class

9.3.6.2.3.             By Disease Indication

9.3.6.2.4.             By Distribution Channel

10.  South America Eye Drop Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Drug Class

10.2.3.  By Disease Indication

10.2.4.  By Distribution Channel

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Eye Drop Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Drug Class

10.3.1.2.3.           By Disease Indication

10.3.1.2.4.           By Distribution Channel

10.3.2.  Argentina Eye Drop Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Drug Class

10.3.2.2.3.           By Disease Indication

10.3.2.2.4.           By Distribution Channel

10.3.3.  Colombia Eye Drop Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Drug Class

10.3.3.2.3.           By Disease Indication

10.3.3.2.4.           By Distribution Channel

11.  Middle East and Africa Eye Drop Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type

11.2.2.  By Drug Class

11.2.3.  By Disease Indication

11.2.4.  By Distribution Channel

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  Turkey Eye Drop Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Drug Class

11.3.1.2.3.           By Disease Indication

11.3.1.2.4.           By Distribution Channel

11.3.2.  South Africa Eye Drop Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Drug Class

11.3.2.2.3.           By Disease Indication

11.3.2.2.4.           By Distribution Channel

11.3.3.  Saudi Arabia Eye Drop Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Drug Class

11.3.3.2.3.           By Disease Indication

11.3.3.2.4.           By Distribution Channel

11.3.4.  UAE Eye Drop Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Type

11.3.4.2.2.           By Drug Class